Sidt2は,p65シグナル伝達による自死流を促進することによって,TNF-α誘発のアポトーシスと炎症を緩和する
Biao Li1, Leilei Wang1, Gengming Zhang1
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School and Hospital of Stomatology, Wuhan University, Wuhan, China.
International immunopharmacology
|August 30, 2025
まとめ
この研究では,Sidt2 (RNA干渉欠陥-1 経膜ファミリーメンバー2) の発現がアピカル歯周炎 (AP) で低下することが示されました. 低レベルのSidt2は,オートファギーを阻害し,p65シグナリングを活性化することで,炎症とアポトーシスを悪化させる.
科学分野:
- 口腔生物学
- 免疫学
- 細胞生物学
背景:
- 歯炎 (apical periodontitis) は,歯骨の喪失を引き起こす一般的な炎症性疾患である.
- 現在,APの病原化におけるSidt2 (RNA干渉欠陥-1トランスメブランファミリーメンバー2) の役割は不明である.
- Sidt2はアポトーシスと炎症反応に関与しています.
研究 の 目的:
- アピカル歯周炎における Sidt2 の役割を調査する.
- APにおけるSidt2の機能の基礎となる分子メカニズムを解明する.
- APの潜在的治療目標としてSidt2を調査する
主な方法:
- APマウスモデルの確立
- TNF-αで治療されたMC3T3- E1およびOCCM-30細胞を用いた試験.
- ウェスタン・ブロットとqRT-PCRによるSidt2発現の分析
- H&E染色,IHC,フローサイトメトリー,ELISA,ウェスタンブロットを用いたアポトーシス,炎症,およびオートファギーの評価.
- p65を含む信号経路の調査
- Sidt2レベルをノックダウンや過剰表現で操作する.
主要な成果:
- Sidt2発現はAPモデルとTNFα治療細胞でダウンレギュレーションされた.
- Sidt2の発現の減少は,アポトーシスと炎症の増加と相関する.
- Sidt2のノックダウンにより,オートファージの流れが低下し,TNFα誘発のアポトーシスと炎症が悪化した.
- Sidt2の過剰発現は反対の効果を示した.
- Sidt2調節されたTNF-α誘発のp65シグナリングとオートファジー.
- 自殺抑制剤は,Sidt2過剰発現する細胞でTNF-α誘発によるいくつかの効果を逆転させた.
結論:
- Sidt2はAPのアポトーシスと炎症反応の負の調節剤として作用する.
- Sidt2は,p65シグナル伝達経路を介して自相流を増強することによって,TNF-α誘発のアポトーシスと炎症を緩和します.
- Sidt2はAPの新しい診断と治療戦略の潜在的なターゲットです.
関連する概念動画
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
The Extrinsic Apoptotic Pathway
6.6K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.6K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K
Autophagic Cell Death
3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K


